Systemic histiocytosis presenting as macrophagic myofasciitis

Journal of Clinical Neuromuscular Disease

Volumn 4, Issue 1, 2002, Pages 19-22

  Simpson, David A ^a  

^a Michigan Institute for Neurological Disorders   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; HEPATITIS B VACCINE; METHOTREXATE; PREDNISONE; VACCINE;

ADULT; AORTA VALVE DISEASE; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; CASE REPORT; CEREBELLUM TENTORIUM; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTRODIAGNOSIS; FASCIITIS; FEMALE; FRANCE; HISTIOCYTE; HISTIOCYTOSIS; HUMAN; MACROPHAGE; MITRAL VALVE DISEASE; MULTIPLE SCLEROSIS; MUSCLE BIOPSY; MUSCLE DISEASE; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; WHITE MATTER;

EID: 0036755972     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200209000-00004     Document Type: Article

References (20)

1. Banker BQ. Other inflammatory myopathies. In: Engel AG, Franzini-Armstrong, eds. Myology, 2nd ed, vol 2. New York: McGraw Hill, 1993:1461-1486.
2. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991;325:1487-1498.
3. Alonzo-Ruiz A, Zea-Mendoza AC, Salazaar-Vallinas JM, et al. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 1986;15: 200-212.
4. Kaufman LD, Seidman RJ, Gruber BL. L-tryptophan-associated eosinophilic perimyositis, neuritis and fasciitis: a clinicopathologic and laboratory study of 25 patients. Medicine 1990;69:187-199.
5. Mayeno AN, Benson LM, Naylor S, et al. Biotransformation of 3-(phenylamino) 1,2-propanediol to 3-(phenylamino) alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. Chem Res Toxicol 1995;8:911-916.
6. Nashitz JE, Boss JH, Miseelevitch I, et al. The fasciitis-panniculitis syndrome: clinical and pathologic features. Medicine 1996; 75:6-16.
7. Snow JL, Daniel Su WP. Histiocytic disorders. J Am Acad Dermatol 1995;33:111-116.
8. Friedlander JS, Weatherall DJ, Ledingham JGG. A chronic granulomatous syndrome of unknown origin. Medicine 1990;69: 325-331.
9. Dobbins WO III. Whipple's disease. In: Conner DH, Chandler FW, Schwartz DA, et al., eds. Pathology of Infectious Diseases, vol 1. Stamford, CT: Appleton and Lange, 1997:897-903.
10. Gillin JS, Urmacher C, West R, et al. Disseminated Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology 1983; 85:1187-1191.
11. Lack EE. Malakoplakia. In: Conner DH, Chandler FW, Schwartz DA, et al., eds. Pathology of Infectious Diseases, vol 2. Stamford, CT: Appleton and Lange, 1997:1647-1654.
12. Miranda D, Vuletin JC, Kauffman SL. Disseminated histiocytosis and intestinal malakoplakia: occurrence due to Mycobacterim intracellulare infection. Arch Pathol Lab Med 1979;103:302-305.
13. Zellger BWH, Sidoroff A, Orchard G, et al. Non-Langerhans cells histiocytosis: a new unifying concept. Am J Dermatopathol 1996;18:490-504.
14. Gherardi RK, Coquet M, Cherin P, et al., for the Group d'Etudes et Recherche sur les Maladies Muscularies Acquises et Dysimmunitaires (GERMMAD) de l'Association Francaise contre les Myopathies (AFM). Macrophagic myofasciitis: an emerging entity. Lancet 1998;352:347-352.
15. Gherardi RK, Coquet M, Belee L, et al., for the GERMMAD. Macrophagic myofasciitis; a reaction to intramuscular injections of aluminum-containing vaccines. J Neurol 1999;246(suppl 1): I/19.
16. Autuier FJ, Cherin P, Creange A, et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001; 124:974-983.
17. Cabello A, Ruiz-Falco ML, Garcia-Pena JJ, et al. Macrophagic myofasciitis. A new case of non-French origin. Neuropathol Appl Neurobiol 1999;25(suppl 1):44.
18. Navarro C, Rodriguez D, Willisch A, et al. Macrophagic myofascitis. A report of a new Spanish case. Neuropathol Appl Neurobiol 1999;25(suppl 1):81.
19. WHO Vaccine Safety Advisory Committee. Macrophagic myofasciitis and aluminum-containing vaccines. Wkly Epidemiol Rec 1999;74:337-340.
20. Smith ME, Katz DA, Harris JO, et al. Systemic histiocytosis presenting as multiple sclerosis. Ann Neurol 1993;33:549-555.